EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Potential Toxic Effects of TBBPA on Embryonic Cardiomyocyte Development and Heartbeat Frequency

Muziqiu Xiao, Xiaowen Peng, Qisheng Liu, Yilu Li, Haoyue Jing, Shaojun Liang, Shan Zhu

Organ Medicine · 2025

DOI: 10.1002/orm2.70003 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Background Tetrabromobisphenol A (TBBPA), the most widely used brominated flame retardant, has raised concerns about its potential embryonic developmental toxicity due to its frequent detection in environmental samples and human body fluids, particularly in umbilical cord blood. TBBPA affects zebrafish heart development, and the heart is the first organ to form, we aim to assess whether it have developmental toxicity on the heart and embryos. Methods This study investigated the effects of environmentally relevant concentrations (1–100 nM) of TBBPA on embryonic development using human embryonic stem cell (hESC)‐derived cardiomyocyte differentiation models and fetal mouse cardiomyocyte models. Results TBBPA exhibited stage‐dependent toxicity during cardiac development, with effects that were largely independent of dose. Specifically, TBBPA disrupted the expression of genes related to cardiomyocyte maturation, reduced the beating frequency of hESC‐derived cardiomyocytes, and accelerated the beating frequency in fetal mouse cardiomyocytes. These differences in beating frequency may be attributed to species‐specific variations. Conclusions TBBPA, at environmentally relevant concentrations, may adversely affect early embryonic development and disrupt cardiac rhythm at later stages.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →